A detailed history of Martingale Asset Management L P transactions in Innoviva, Inc. stock. As of the latest transaction made, Martingale Asset Management L P holds 77,842 shares of INVA stock, worth $1.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
77,842
Previous 77,292 0.71%
Holding current value
$1.5 Million
Previous $1.27 Million 18.55%
% of portfolio
0.04%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.33 - $20.04 $8,981 - $11,022
550 Added 0.71%
77,842 $1.5 Million
Q1 2024

May 14, 2024

BUY
$14.56 - $16.78 $20,384 - $23,492
1,400 Added 1.84%
77,292 $1.18 Million
Q3 2023

Nov 14, 2023

SELL
$12.37 - $13.89 $581 - $652
-47 Reduced 0.06%
75,892 $985,000
Q2 2023

Aug 11, 2023

BUY
$11.39 - $13.72 $22,791 - $27,453
2,001 Added 2.71%
75,939 $966,000
Q1 2023

May 12, 2023

BUY
$10.73 - $13.6 $30,280 - $38,379
2,822 Added 3.97%
73,938 $831,000
Q4 2022

Feb 13, 2023

BUY
$11.8 - $13.78 $24,272 - $28,345
2,057 Added 2.98%
71,116 $942,000
Q3 2022

Nov 14, 2022

SELL
$11.61 - $15.22 $303,253 - $397,546
-26,120 Reduced 27.44%
69,059 $803,000
Q2 2022

Aug 11, 2022

SELL
$14.32 - $19.88 $200 - $278
-14 Reduced 0.01%
95,179 $1.4 Million
Q1 2022

May 12, 2022

BUY
$15.39 - $20.25 $408,635 - $537,678
26,552 Added 38.68%
95,193 $1.84 Million
Q4 2021

Feb 11, 2022

BUY
$15.91 - $18.72 $240,113 - $282,522
15,092 Added 28.18%
68,641 $1.18 Million
Q3 2021

Nov 12, 2021

BUY
$13.06 - $17.24 $543,296 - $717,183
41,600 Added 348.15%
53,549 $894,000
Q2 2021

Aug 13, 2021

BUY
$11.45 - $13.96 $136,816 - $166,808
11,949 New
11,949 $160,000
Q1 2021

May 13, 2021

SELL
$11.06 - $12.87 $256,027 - $297,927
-23,149 Closed
0 $0
Q4 2020

Feb 10, 2021

SELL
$9.33 - $12.48 $405,855 - $542,880
-43,500 Reduced 65.27%
23,149 $286,000
Q3 2020

Nov 12, 2020

SELL
$10.33 - $14.49 $583,645 - $818,685
-56,500 Reduced 45.88%
66,649 $696,000
Q2 2020

Aug 10, 2020

SELL
$11.49 - $15.26 $68 - $91
-6 Reduced -0.0%
123,149 $1.72 Million
Q1 2020

May 11, 2020

BUY
$8.11 - $15.23 $998,787 - $1.88 Million
123,155 New
123,155 $1.45 Million
Q1 2019

May 08, 2019

SELL
$13.69 - $20.06 $586,616 - $859,571
-42,850 Closed
0 $0
Q4 2018

Feb 11, 2019

BUY
$13.96 - $18.26 $598,186 - $782,441
42,850 New
42,850 $747,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.34B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.